Business Wire

Fluence Returns to MJBizCon, Releases Ninth Annual Cannabis Business Times “State of the Cannabis Lighting Market” Report

21.11.2024 15:00:00 CET | Business Wire | Press release

Share

Industry leader in cannabis lighting to showcase latest top light, multi-tier and supplemental lighting solutions at 2024 MJBizCon

Fluence, a leading global provider of energy-efficient LED lighting solutions for commercial cannabis production, released the ninth annual “State of the Cannabis Lighting Market” report in collaboration with Cannabis Business Times, a publication focused on accelerating the success and acceptance of the cannabis market by providing actionable intelligence to help all aspects of the business.

Headlining this year’s report is more evidence of the rapid and consistent adoption of LED technology among cannabis growers. Survey respondents also noted increased interest in augmenting their top light solutions with side, intercanopy or sub-canopy lighting.

“LED adoption is on the precipice of becoming the universal standard for critical phases of cannabis cultivation, delivering greater yields than HPS with less heat and energy consumption—without sacrificing crop quality,” said Dr. David Hawley, principal scientist for Fluence. “For growers, those benefits have catalyzed an interest in adding even more energy within the canopy via intercanopy and sub- or under-canopy lighting, which Fluence research has shown could produce greater yields and higher-quality buds in the lower canopy when deployed additively to top lighting.”

Major findings from the report include:

  • Seventy-eight percent of survey participants reported using LEDs for the vegetative phase, while 77% reported using LEDs for flowering—up 61 and 62 percentage points, respectively, from the report’s inaugural publishing in 2016.
  • Sixty-five percent of commercial growers considering adding lighting in the next 12 months want to explore ways to augment top lighting, such as side, intercanopy or sub-canopy fixtures. Growers’ interest in intercanopy lighting grew 10 percentage points from 2023.
  • Forty-two percent of participants ranked “crop quality” as the most important consideration for LED adoption.
  • Twenty-three percent of growers surveyed said 40% to 50% red was the most important spectral property for the flowering phase.

The report precedes MJBizCon’s 2024 event, where Fluence will showcase the latest products in its VYPR, RAPTR, SPYDR and VYNE series. The company will also host public fireside chats at its booth with leading cannabis researchers and growers, including Travis Higginbotham, founder and CEO of Due Diligence Horticulture, and Dave Holmes, founder and CEO of Clade9.

“Cannabis growers are natural innovators. They move quickly to adopt new technology and customize applications in their facilities. They confer with each other, seeking to learn from the brightest minds in the industry in the pursuit of advancing cultivation,” said Steve Graves, Fluence’s senior vice president of strategy and business development, in his opening letter for the “State of the Cannabis Lighting Market” report.

“We look forward to fostering new connections at MJBizCon while showcasing how our lighting technology will help growers boost plant quality and exceed their business goals,” Graves added.

Dr. Hawley will also explore the rising interest in intercanopy lighting during his MJBizCon session—“Maximizing Cannabis Yield with Intercanopy Lighting: Strategies and Best Practices”—which will take place at 10:50 a.m. PST on Dec. 5 in Room 1. Find Fluence on the Expo Floor at booth No. 43023.

For more information about this year’s “State of the Cannabis Lighting Market” report, visit the Fluence website or secure a copy at Fluence’s MJBizCon booth.

About Fluence

Fluence Bioengineering, Inc. (Fluence) creates powerful and energy-efficient LED lighting solutions for commercial crop production and research applications. Fluence is a leading LED lighting supplier in the global cannabis market, committed to enabling more efficient crop production for the world’s top greenhouse and indoor growers. Fluence global headquarters are in Austin, Texas, with its EMEA headquarters in Eindhoven, Netherlands. Fluence operates within Signify’s Agricultural Lighting business unit. For more information about Fluence, visit www.fluence-led.com.

Methodology

Independent research firm Readex Research conducted the study and compiled the data for the 2024 “State of the Cannabis Lighting Market” report. During August 2024, a research questionnaire was sent to all emailable, active subscribers to Cannabis Business Times located in the United States or Canada. To present data most pertinent to commercial cannabis cultivators, this research focuses on the 189 research participants who currently own or work for an operation that grows cannabis in an indoor facility and/or greenhouse. Data was then refined to exclude non-commercial operations. Unless otherwise indicated, the results found within this report represent participants who cultivate cannabis commercially indoors and/or in greenhouses, with or without supplemental lighting. The margin of error for percentages based on the 189 participants who reported they currently own or work for an operation that grows cannabis in an indoor facility and/or greenhouse is ±7.1 percentage points at the 95% confidence level.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241121961674/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Vertex Presents New Data on ALYFTREK® at European Cystic Fibrosis Conference5.6.2026 18:00:00 CEST | Press release

- ALYFTREK Phase 3 data on children with cystic fibrosis ages 2 to 5 with vanzacaftor/tezacaftor/deutivacaftor-responsive genotypes including F/F and F/MF shows 65% reached sweat chloride levels of <30 mmol/L; Vertex on track to initiate global regulatory submissions in first half of 2026 - - Long-term 96-week interim analyses from two open-label extension studies demonstrate positive safety and efficacy profile of ALYFTREK in people with cystic fibrosis ages 6 and older -- Phase 3 data on TRIKAFTA® in children 1 to <2 years also presented; Vertex has initiated global regulatory submissions - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data demonstrating the potentially transformative impact of treating cystic fibrosis (CF) with ALYFTREK ® (vanzacaftor/tezacaftor/deutivacaftor) in children ages 2 to 5, as well as data from 96-week interim analyses of two open-label extension studies of ALYFTREK in children 6 to 11 years and people 12 years and older demonstrating

Owkin to Build AI Agents as Part of a Multi-Year K Pro Collaboration with Sanofi5.6.2026 13:00:00 CEST | Press release

Owkin, the agentic AI company pioneering Biological Artificial Superintelligence to transform drug discovery and development, today announced a multi-year collaboration with Sanofi to co-develop next-generation biopharma agents, to be backed by a five-year license for K Pro, Owkin’s AI Scientist. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260605704506/en/ K Pro, Owkin's AI scientist for biology, powered by multimodal patient data for smarter biopharma decision making. Owkin and Sanofi have collaborated since 2021 through a €90 million strategic partnership focused on target identification in oncology and patient subgrouping. The collaboration was later expanded to include drug positioning for Sanofi’s immunology pipeline. This new collaboration represents the next evolution in the partnership. During the five-year collaboration, Owkin will lead the end-to-end development of novel AI-driven biopharma agents purpose-built

DFNS Rebrands as the Core Banking Platform for Digital Assets5.6.2026 12:41:00 CEST | Press release

DFNS today announced a rebrand, marking its evolution from a wallet infrastructure to the first core banking platform for digital assets. The company is introducing a new logo, website, and market position as fintechs and institutions move their products and operations onchain. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260603859127/en/ Banks, fintechs, asset managers, trading firms, payment providers, market infrastructures, and clearing houses have stopped asking how to "add crypto." They're asking how to run financial products, controls, workflows, and client services on blockchain rails, with the reliability expected of core infrastructure. Some are going further still, exploring whether the blockchain can serve as the ledger itself, where an account is an onchain object rather than a row in a database. Where IBANs, virtual accounts, and blockchain wallets converge into one governed financial account. “DFNS was built

Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)5.6.2026 12:30:00 CEST | Press release

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to seventeen newly hired non-executive employees. The equity awards were granted on June 1, 2026 and consisted of options to purchase an aggregate of 157,000 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 74,700 shares. The options have an exercise price per share equal to $14.19, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restrict

Renewable Electricity, Soft Wheat Flour From Regenerative Agriculture, Initiatives to Support Local Communities: Barilla Shares These and Other Projects in “Stories of Sustainability.”5.6.2026 10:00:00 CEST | Press release

Barilla continues to advance its commitment to tastier products with less sugar and salt;An investment of 30 million euros in 2025 to quadruple photovoltaic capacity across plants, as part of a €168 million five-year plan focused on energy efficiency, renewable energy and sustainable water management.Barilla continues to expand regenerative agriculture practices across its global value chain, with over 816,000 tons of raw materials sourced through the Barilla Sustainable Farming program.4,000 tons of products donated worldwide and €2 million allocated to social causes in 2025, supporting communities across Barilla’s global footprint through food donations and social initiatives. A slimmer Tagliatelle pack that saves 150 tons of cardboard and cuts transport-related CO₂ emissions by 20%1; ready-made sauce jars made with around 65% recycled glass; the progressive scaling of regenerative agriculture practices across Barilla’s value chain and initiatives supporting inclusion and equal oppor

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye